Guadagnuolo V, Papayannidis C, Iacobucci I, et al. SIRPB1: biomarker of response to 5-azacitidine treatment in MDS and AML patients. EHA 2017, abstract E1201.
Antilichaam-therapie vermindert graft-versus-host ziekte
jan 2017 | Leukemie, Stamceltransplantatie